BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35776774)

  • 1. Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study.
    Zuo Z; Cui H; Wang M; Huang C; Wu J; Tao C; Li Z; Yang C; Pan K; Bao J; Liu S; Xu A
    PLoS One; 2022; 17(7):e0270512. PubMed ID: 35776774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of FibroTouch and six serological models for assessing the degree of liver fibrosis in patients with chronic hepatitis B].
    Zuo ZB; Cui HZ; Huang CX; Guo Y; Pan KR; Wang MC; Du W; Huang B; Xu AF
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):430-435. PubMed ID: 31357758
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Peng X; Tian A; Li J; Mao Y; Jiang N; Li T; Mao X
    Dig Dis Sci; 2022 Jun; 67(6):2627-2636. PubMed ID: 34059990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].
    Wang R; Ren W; Zhao S; Niu X; Tan P; Du H; Nan Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):265-9. PubMed ID: 26133817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study.
    Xu Y; Liu Y; Cao Z; Wang L; Li Z; Sheng Z; Cai W; Wang H; Bao S; Xie Q
    Dig Liver Dis; 2019 Sep; 51(9):1323-1329. PubMed ID: 30928419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of FibroTouch combined with four hepatic fibrosis biomarkers for evaluation of the liver fibrosis degree among patients with chronic schistosomiasis-induced liver disorders].
    Hong Y; Niu XH; Shen YZ; Zhou L; Huang LP
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):629-633. PubMed ID: 35128895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis.
    Yang XZ; Gen AW; Xian JC; Xiao L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):479-485. PubMed ID: 29424906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of FibroTouch and acoustic radiation force impulse in diagnosis of liver fibrosis in patients with chronic hepatitis B].
    Liu F; Wei L; Wang S; Huang B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):416-421. PubMed ID: 27868416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis B.
    Duan WJ; Wang XZ; Ma AL; Shang J; Nan YM; Gao ZL; Tang H; Fu QC; Xie Q; Mao Q; Niu JQ; Han T; Li J; Han Y; Cao JB; Kong YY; Shi XY; Lv FD; Wang TL; Ma H; You H; Ou XJ; Jia JD
    J Dig Dis; 2020 Sep; 21(9):519-525. PubMed ID: 32700794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease].
    An XY; Qiao J; Hu LX; Wang RQ; Nan YM
    Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):49-53. PubMed ID: 36631037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation of FibroTouch and FibroScan with the stage of primary biliary cirrhosis].
    Zhang YG; Zhao SX; Zhou GD; Li WC; Ren WG; Du HJ; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):902-906. PubMed ID: 28073410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of liver stiffness measurement for the evaluation of liver fibrosis in nonalcoholic fatty liver].
    Ning J; Yao MJ; Liu SH; Zhou GD; Zhang Y; Li MY; Wang LJ; Wang L; Zhao JM; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):567-572. PubMed ID: 32791791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease].
    He SL; Li SJ; Liu M; Ouyang WX; Chen WJ; Zheng X; Jiang T; Tan YF; Kang Z; Qin XM; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):81-86. PubMed ID: 35152674
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus.
    Yu H; Liu H; Zhang J; Jia G; Yang L; Zhang Q; Li G; Liu F; Di F; Wang F
    Ann Palliat Med; 2021 Sep; 10(9):9702-9714. PubMed ID: 34628896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].
    Zhang XY; Qian J; Li P; Hu LH; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):332-336. PubMed ID: 29996199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Establishment and preliminary application of serum Golgi protein 73 based noninvasive diagnostic model for compensated stage hepatitis B cirrhosis].
    Zhai XW; Liu SH; Yao MJ; Qian XJ; Wen XJ; Xu Q; Zhao JM; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):47-52. PubMed ID: 32023699
    [No Abstract]   [Full Text] [Related]  

  • 19. [FibroTouch diagnostic efficiency and influencing factors for liver fibrosis in autoimmune liver diseases].
    Yan JJ; Wang WJ; Fan HQ; Pan XL; Du F; Deng XL; Song YH; Ye J; Xu KS; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1048-1051. PubMed ID: 34865354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.